Pharmaceutical compound
Dosergoside (INNTooltip International Nonproprietary Name), also known as lyrgosin or N-(dihydrolysergyl)sphingosine, is a dopamine agonist of the ergoline and lysergamide families which was never marketed.[1] It is similar in chemical structure to lysergic acid diethylamide (LSD) but is 9,10-dihydrogenated and features a sphingosine moiety in place of LSD’s N,N-diethylamide group.[1] The drug was first described in the literature by 1981.[1]
See also
References
- ^ a b c Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 468. ISBN 978-1-4757-2085-3. Retrieved 30 June 2025.
| Ergolines (incl. lysergines) |
|
|---|---|
| Clavines (6,8-dimethylergolines) | |
| Lysergamides (lysergic acid amides) |
|
| Ergopeptines (peptide ergolines) |
|
| Partial ergolines |
|
| Related compounds | |
| Natural sources |
|